Anemic state of patients with breast cancer with multiple bone metastases during the courses of systematic radionuclide therapy

##plugins.themes.bootstrap3.article.sidebar##

PDF (Українська)
Published: May 18, 2017
DOI: https://doi.org/10.30841/2307-5112.2(70).2017.114709
Keywords:
anemia, systematic radionuclide therapy, breast cancer, multiple bone metastases,

##plugins.themes.bootstrap3.article.main##

М. М. Фірсова
Національна медична академія післядипломної освіти імені П.Л. Шупика, м. Київ, Ukraine

Abstract

Тhe article contains analysis of anemia cases that have been registered in patients with breast cancer with multiple bone metastases during the courses of systematic radionuclide treatment. The anemia cases have been registered in 60 65% of patients, disregarding of exact radiopharmaceutical applied. Average period of anemia appearance was 4-6 weeks. Level of anemia manifestation was dependent on initial medical status of patients and their subjective compensatory abilities. Anemia in this category of patients is to greater extend linked to the prolongation of their main disease. Anemic states are not registered during remission and stabilization processes after steady therapeutic effect is achieved in radionuclide treatment courses.

##plugins.themes.bootstrap3.article.details##

How to Cite
Фірсова, М. М. (2017). Anemic state of patients with breast cancer with multiple bone metastases during the courses of systematic radionuclide therapy. Family Medicine, (2(70), 24–27. https://doi.org/10.30841/2307-5112.2(70).2017.114709
Issue
No. 2(70) (2017)
Section
Topical issues
Copyright (c) 2020 М. М. Фірсова

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.

Author Biography

М. М. Фірсова, Національна медична академія післядипломної освіти імені П.Л. Шупика, м. Київ

M. Firsova

References

Breder V.V. Аnemija pry rake molochnoj zhelezy. Mаmmоlоgija, 2006, no. 3, pp. 48–53.

Dolezal J., Vizda’a J., Cermacova E. Myelotoxicity after systemic radionuclide therapy of painful bone metastases with 153 Samarium – EDTMP. Vnitr. Lek, 2003, vol. 49, pp. 189–193.

Gaidukova S.М., Vydyborets S.V., Sivak L.А., Pjasets’ka N.М. Аnemii: navchal’nyj posibnyk. – К.: Тry Krapky, 2005. – 312 p.

Leonard R.C., Untch M., von Koch F. Management of anemia in patients with breast cancer: role of epoetin. Ann. Oncol., 2005, vol. 16, pp. 817–824.

Lewington V.J. Bone – Seeking Radionuclides for Therapy. J. Nucl. Med, 2005, vol. 46, no 1 (Suppl), pp. S38–S47.

Portjagin I.V., Rjazankina A.A., Kvashin A.V. Simptomaticheskaja terapija pri rake predstatel’noj zhelezy. Prakticheskaja onkologija, 2008, vol. 9, no. 2, p. 117–123.

Prohach А.V. Vlijanije gematologicheskich oslozhnenij na effektivnost’ sistemnoj terapii raka molochnoj zhelezy. Medychni perspektyvy, 2016, vol. 21, no. 2, pp. 75–77.

Rodionov V.V., Petrov S.V., Rahmattulina E.Т., Suetin А.V. Opuholevoe porazhenije kostnogo mozga u bol’nuh rakom molochnoj zhelezy. Hirurgija, 2006, no. 3(17), pp. 51–54.

Snegovoj А.V. Problema zhelezodefizitnij anemii u pazientov s onkologichaskimi zabolevanijami: praktika primenenija zhelezosoderzhachih preparatov. Sovremennaja onkologija, 2013, vol. 15, no. 2, pp. 65–72.

Vydyborets S.V., Andriiaka А.А. Sovremennyje princypy lechenija anemii u pazientov s onkogematologicheskimi i onkologicheskimi zabolevanijami [Modern strategy to management of anemia in patient with hematologic and solid tumors] treatment. Gematologija. Transfusiologija: Vostochnaja Evropa. 2016, vol. 2, no. 3, pp. 388–397.

Vydyborets S.V., Gaidukova S.N. Sovremennaja taktika diagnostiki i letchenie zelezodeficitnoj anemii [Modern diagnostic and treatment strategy of iron deficient anemia]. Gematologija. Transfusiologija: Vostochnaja Evropa. 2015, no. 2(02), pp. 105–121.